{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:47:14Z","timestamp":1791319634969,"version":"4.3.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T00:00:00Z","timestamp":1405382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["KUN2010-4722"],"award-info":[{"award-number":["KUN2010-4722"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["KUN2009-4402"],"award-info":[{"award-number":["KUN2009-4402"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ENCITE","award":["HEALTH-F5-2008-201842"],"award-info":[{"award-number":["HEALTH-F5-2008-201842"]}]},{"name":"The Netherlands Organization for Scientific Research","award":["NWO-Vidi-917.76.363"],"award-info":[{"award-number":["NWO-Vidi-917.76.363"]}]},{"name":"Nijmeegs Offensief Tegen Kanker Foundation"},{"DOI":"10.13039\/501100002908","name":"Stichting Combined Ophthalmic Research Rotterdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002908","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stichting Wetenschappelijk Onderzoek het Oogziekenhuis"},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2010-AdG-269019-PATHFINDER"],"award-info":[{"award-number":["ERC-2010-AdG-269019-PATHFINDER"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ajo.2014.07.014","type":"journal-article","created":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T22:46:03Z","timestamp":1405550763000},"page":"939-947.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients"],"prefix":"10.1016","volume":"158","author":[{"given":"Kalijn F.","family":"Bol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke W.","family":"Mensink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik H.J.G.","family":"Aarntzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerty","family":"Schreibelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan E.E.","family":"Keunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre G.","family":"Coulie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"de Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J.A.","family":"Punt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dion","family":"Paridaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl G.","family":"Figdor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Jolanda M.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajo.2014.07.014_bib1","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","article-title":"Incidence of uveal melanoma in Europe","volume":"114","author":"Virgili","year":"2007","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2014.07.014_bib2","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2014.07.014_bib3","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/IAE.0b013e31824d09a8","article-title":"Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases","volume":"32","author":"Shields","year":"2012","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.ajo.2014.07.014_bib4","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"31","key":"10.1016\/j.ajo.2014.07.014_bib5","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1200\/JCO.2005.02.6534","article-title":"Variates of survival in metastatic uveal melanoma","volume":"23","author":"Rietschel","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ajo.2014.07.014_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/CMR.0b013e3283457726","article-title":"Metastatic uveal melanoma: is there a role for conventional chemotherapy? A single center study based on 58 patients","volume":"21","author":"Pons","year":"2011","journal-title":"Melanoma Res"},{"issue":"2","key":"10.1016\/j.ajo.2014.07.014_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncr.11113","article-title":"A prognostic model and staging for metastatic uveal melanoma","volume":"97","author":"Eskelin","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ajo.2014.07.014_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajo.2011.03.004","article-title":"Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival","volume":"152","author":"Augsburger","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2014.07.014_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(96)80024-5","article-title":"Prognostic parameters in uveal melanoma: a review","volume":"41","author":"Mooy","year":"1996","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2014.07.014_bib10","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.ophtha.2013.03.012","article-title":"American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients","volume":"120","author":"Shields","year":"2013","journal-title":"Ophthalmology"},{"issue":"22","key":"10.1016\/j.ajo.2014.07.014_bib11","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.2012.45.2771","article-title":"Staging of ciliary body and choroidal melanomas based on anatomic extent","volume":"31","author":"Kujala","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ajo.2014.07.014_bib12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0161-6420(03)00077-0","article-title":"Survival rates with uveal melanoma in the United States: 1973\u20131997","volume":"110","author":"Singh","year":"2003","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2014.07.014_bib13","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1167\/iovs.03-0081","article-title":"Uveal melanoma survival in Sweden from 1960 to 1998","volume":"44","author":"Bergman","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2014.07.014_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1600-0420.2004.00329.x","article-title":"Have choroidal and ciliary body melanomas changed during the period 1955\u20132000?","volume":"82","author":"Isager","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"issue":"3","key":"10.1016\/j.ajo.2014.07.014_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0002-9394(98)00091-9","article-title":"The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma III: local complications and observations following enucleation COMS report no. 11","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2014.07.014_bib16","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archopht.119.5.670","article-title":"Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2014.07.014_bib17","first-page":"128","article-title":"Quality of evidence about effectiveness of treatments for metastatic uveal melanoma","volume":"106","author":"Augsburger","year":"2008","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"3","key":"10.1016\/j.ajo.2014.07.014_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0161-6420(91)32285-1","article-title":"Survival of patients with metastases from uveal melanoma","volume":"98","author":"Gragoudas","year":"1991","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2014.07.014_bib19","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","article-title":"Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group report no. 26","volume":"123","author":"Diener-West","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2014.07.014_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/cncr.11872","article-title":"Prolonged survival after complete resection of metastases from intraocular melanoma","volume":"100","author":"Hsueh","year":"2004","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ajo.2014.07.014_bib21","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/1097-0142(19931001)72:7<2219::AID-CNCR2820720725>3.0.CO;2-J","article-title":"Prognosis and treatment of disseminated uveal melanoma","volume":"72","author":"Kath","year":"1993","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ajo.2014.07.014_bib22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajo.2014.07.014_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/CMR.0b013e32835b554f","article-title":"Ipilimumab activity in advanced uveal melanoma","volume":"23","author":"Khattak","year":"2013","journal-title":"Melanoma Res"},{"issue":"1","key":"10.1016\/j.ajo.2014.07.014_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00262-011-1089-0","article-title":"Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy","volume":"61","author":"Danielli","year":"2012","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"10.1016\/j.ajo.2014.07.014_bib25","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/bjo.2006.110908","article-title":"Presence and phenotype of dendritic cells in uveal melanoma","volume":"91","author":"Polak","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2014.07.014_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000267140","article-title":"Infiltrating lymphocytes and antigen expression in uveal melanoma","volume":"24","author":"Meecham","year":"1992","journal-title":"Ophthalmic Res"},{"issue":"1","key":"10.1016\/j.ajo.2014.07.014_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00186516","article-title":"HLA expression and tumor-infiltrating immune cells in uveal melanoma","volume":"234","author":"de Waard-Siebinga","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"23","key":"10.1016\/j.ajo.2014.07.014_bib28","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1158\/0008-5472.CAN-12-2479","article-title":"Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-based vaccination in metastatic melanoma","volume":"72","author":"Aarntzen","year":"2012","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.ajo.2014.07.014_bib29","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/bjc.1998.646","article-title":"High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma","volume":"78","author":"de Vries","year":"1998","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ajo.2014.07.014_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0161-6420(93)31668-4","article-title":"Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors","volume":"100","author":"Steuhl","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2014.07.014_bib31","first-page":"113","article-title":"Phenotypical and functional characterization of clinical-grade dendritic cells","volume":"109","author":"de Vries","year":"2005","journal-title":"Methods Mol Med"},{"issue":"5","key":"10.1016\/j.ajo.2014.07.014_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nm1039","article-title":"Dendritic cell immunotherapy: mapping the way","volume":"10","author":"Figdor","year":"2004","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.ajo.2014.07.014_bib33","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1200\/JCO.2005.06.478","article-title":"Immunomonitoring tumor-specific T\u00a0cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome","volume":"23","author":"de Vries","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ajo.2014.07.014_bib34","first-page":"534","article-title":"Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in\u00a0situ hybridization","volume":"8","author":"Naus","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"3\u20134","key":"10.1016\/j.ajo.2014.07.014_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000132971","article-title":"Cytogenetic analysis of human solid tumors by in\u00a0situ hybridization with a set of 12 chromosome-specific DNA probes","volume":"54","author":"van Dekken","year":"1990","journal-title":"Cytogenet Cell Genet"},{"issue":"5","key":"10.1016\/j.ajo.2014.07.014_bib36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.preteyeres.2009.06.002","article-title":"Immune escape mechanisms of intraocular tumors","volume":"28","author":"Niederkorn","year":"2009","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2014.07.014_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/09273941003669950","article-title":"Influence of immune privilege on ocular tumor development","volume":"18","author":"McKenna","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.ajo.2014.07.014_bib38","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.4049\/jimmunol.180.6.3766","article-title":"Modulation of the tumor cell phenotype by IFN-gamma results in resistance of uveal melanoma cells to granule-mediated lysis by cytotoxic lymphocytes","volume":"180","author":"Hallermalm","year":"2008","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.ajo.2014.07.014_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF01756599","article-title":"Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients","volume":"33","author":"Kan-Mitchell","year":"1991","journal-title":"Cancer Immunol Immunother"},{"issue":"12","key":"10.1016\/j.ajo.2014.07.014_bib40","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.4049\/jimmunol.165.12.7308","article-title":"Adoptive T\u00a0cell immunotherapy of human uveal melanoma targeting gp100","volume":"165","author":"Sutmuller","year":"2000","journal-title":"J Immunol"},{"issue":"database issue","key":"10.1016\/j.ajo.2014.07.014_bib41","doi-asserted-by":"crossref","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","article-title":"Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations","volume":"39","author":"Gonzalez-Galarza","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.ajo.2014.07.014_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.05-1122","article-title":"HLA class I and II genotype in uveal melanoma: relation to occurrence and prognosis","volume":"47","author":"Maat","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2014.07.014_bib43","series-title":"American Joint Committee on Cancer: Cancer Staging Manual","author":"Edge","year":"2010"},{"issue":"7","key":"10.1016\/j.ajo.2014.07.014_bib44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00432-004-0569-4","article-title":"Clinical evaluation of\u00a0in\u00a0vitro chemosensitivity testing: the example of uveal\u00a0melanoma","volume":"130","author":"Terheyden","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"issue":"18 Pt 1","key":"10.1016\/j.ajo.2014.07.014_bib45","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1158\/1078-0432.CCR-07-0892","article-title":"Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment","volume":"13","author":"Gajewski","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"9010","key":"10.1016\/j.ajo.2014.07.014_bib46","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ajo.2014.07.014_bib47","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<354::AID-CNCR20>3.0.CO;2-R","article-title":"Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma","volume":"83","author":"White","year":"1998","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ajo.2014.07.014_bib48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/CMR.0b013e32830317de","article-title":"Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients","volume":"18","author":"Voelter","year":"2008","journal-title":"Melanoma Res"},{"issue":"11","key":"10.1016\/j.ajo.2014.07.014_bib49","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.ophtha.2009.04.044","article-title":"Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis","volume":"116","author":"Lane","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2014.07.014_bibe1","first-page":"113","article-title":"Phenotypical and functional characterization of clinical-grade dendritic cells","volume":"109","author":"de Vries","year":"2005","journal-title":"Methods Mol Med"},{"issue":"3","key":"10.1016\/j.ajo.2014.07.014_bibe2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1158\/0008-5472.CAN-12-2583","article-title":"Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients","volume":"73","author":"Tel","year":"2013","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ajo.2014.07.014_bibe3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1158\/0008-5472.CAN-12-1127","article-title":"Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination","volume":"73","author":"Aarntzen","year":"2013","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.ajo.2014.07.014_bibe4","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/0008-5472.CAN-08-3920","article-title":"In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients","volume":"69","author":"Schuurhuis","year":"2009","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ajo.2014.07.014_bibe5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nm1039","article-title":"Dendritic cell immunotherapy: mapping the way","volume":"10","author":"Figdor","year":"2004","journal-title":"Nat Med"},{"issue":"23","key":"10.1016\/j.ajo.2014.07.014_bibe6","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1158\/0008-5472.CAN-12-2479","article-title":"Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-based vaccination in metastatic melanoma","volume":"72","author":"Aarntzen","year":"2012","journal-title":"Cancer Res"},{"issue":"24","key":"10.1016\/j.ajo.2014.07.014_bibe7","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1200\/JCO.2005.06.478","article-title":"Immunomonitoring tumor-specific T\u00a0cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome","volume":"23","author":"de Vries","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1\u20132","key":"10.1016\/j.ajo.2014.07.014_bibe8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jim.2011.12.010","article-title":"Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigens","volume":"377","author":"Van Nuffel","year":"2012","journal-title":"J Immunol Methods"},{"issue":"9","key":"10.1016\/j.ajo.2014.07.014_bibe9","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.4049\/jimmunol.171.9.4898","article-title":"Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus","volume":"171","author":"Karanikas","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ajo.2014.07.014_bibe10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00262-010-0942-x","article-title":"Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used","volume":"60","author":"Lesterhuis","year":"2011","journal-title":"Cancer Immunol Immunother"},{"issue":"20","key":"10.1016\/j.ajo.2014.07.014_bibe11","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1158\/1078-0432.CCR-10-1757","article-title":"Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I\/II study in metastatic melanoma patients","volume":"16","author":"Jacobs","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ajo.2014.07.014_bibe12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1158\/0008-5472.CAN-12-1127","article-title":"Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination","volume":"73","author":"Aarntzen","year":"2013","journal-title":"Cancer Res"},{"issue":"19","key":"10.1016\/j.ajo.2014.07.014_bibe13","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1158\/1078-0432.CCR-11-3368","article-title":"Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T\u00a0cells responses in stage III and IV melanoma patients","volume":"18","author":"Aarntzen","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ajo.2014.07.014_bibe14","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1158\/0008-5472.CAN-12-2583","article-title":"Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients","volume":"73","author":"Tel","year":"2013","journal-title":"Cancer Res"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293941400405X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293941400405X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:12:19Z","timestamp":1757596339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293941400405X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S000293941400405X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2014.07.014","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2014.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}